A phase I study to assess the safety, tolerability, and pharmacokinetics of CXD101 in patients with advanced cancer

Cancer, EarlyView.

Source: Cancer - October 17, 2018 Category: Cancer & Oncology Authors: Toby A. Eyre, Graham P. Collins, Avinash Gupta, Nicholas Coupe, Semira Sheikh, John Whittaker, Lai Mun Wang, Leticia Campo, Elizabeth Soilleux, Finn Tysoe, Richard Cousins, Nick La Thangue, Lisa K. Folkes, Michael R.L. Stratford, David Kerr, Source Type: research